These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 10498840

  • 1. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.
    Chiou LC.
    Br J Pharmacol; 1999 Sep; 128(1):103-7. PubMed ID: 10498840
    [Abstract] [Full Text] [Related]

  • 2. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC, Fan SH, Guerrini R, Caló G.
    Neuropharmacology; 2002 Feb; 42(2):246-52. PubMed ID: 11804621
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray.
    Chiou LC.
    J Biomed Sci; 2000 Feb; 7(3):232-40. PubMed ID: 10810242
    [Abstract] [Full Text] [Related]

  • 4. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ, Liao YY, Guerrini R, Calo' G, Chiou LC.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):110-5. PubMed ID: 17976580
    [Abstract] [Full Text] [Related]

  • 5. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC, Chuang KC, Wichmann J, Adam G.
    J Pharmacol Exp Ther; 2004 Nov 28; 311(2):645-51. PubMed ID: 15254141
    [Abstract] [Full Text] [Related]

  • 6. Nociceptin/orphanin FQ and [Phe(1)psi(CH2-NH)Gly2]nociceptin(1-13)NH2 modulates the activity of hypothalamic paraventricular nucleus neurons in vitro.
    Shirasaka T, Miyahara S, Takasaki M, Kannan H.
    Brain Res; 2001 Jan 26; 890(1):147-53. PubMed ID: 11164777
    [Abstract] [Full Text] [Related]

  • 7. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY, Trapella C, Chiou LC.
    Eur J Pharmacol; 2009 Mar 15; 606(1-3):84-9. PubMed ID: 19374842
    [Abstract] [Full Text] [Related]

  • 8. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
    Chiou LC.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun 15; 363(6):583-9. PubMed ID: 11414652
    [Abstract] [Full Text] [Related]

  • 9. [Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray.
    Chiou LC, Liao YY, Guerrini R, Calo' G.
    Eur J Pharmacol; 2005 May 16; 515(1-3):47-53. PubMed ID: 15896734
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
    Chiou LC, Fan SH, Chuang KC, Liao YY, Lee SZ.
    Ann N Y Acad Sci; 2004 Oct 16; 1025():398-403. PubMed ID: 15542742
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ.
    Meis S, Pape HC.
    J Neurosci; 1998 Oct 15; 18(20):8133-44. PubMed ID: 9763460
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CompB (J-113397), selectively and competitively antagonizes nociceptin activation of inwardly rectifying K(+) channels in rat periaqueductal gray slices.
    Chiou LC, Fan SH.
    Neuropharmacology; 2002 Jun 15; 42(7):987-92. PubMed ID: 12069909
    [Abstract] [Full Text] [Related]

  • 17. Effect of nociceptin and [Phe1psi (CH2-NH) Gly2]-nociceptin-(1-13)-NH2 on tonic activity of rat hypothalamic neurons.
    Yakimova KS, Pierau FK.
    Neurosci Lett; 1999 Oct 22; 274(2):87-90. PubMed ID: 10553944
    [Abstract] [Full Text] [Related]

  • 18. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro.
    Connor M, Vaughan CW, Chieng B, Christie MJ.
    Br J Pharmacol; 1996 Dec 22; 119(8):1614-8. PubMed ID: 8982509
    [Abstract] [Full Text] [Related]

  • 19. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord.
    Xu IS, Wiesenfeld-Hallin Z, Xu XJ.
    Neurosci Lett; 1998 Jun 19; 249(2-3):127-30. PubMed ID: 9682833
    [Abstract] [Full Text] [Related]

  • 20. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
    Kapusta DR, Chang JK, Kenigs VA.
    J Pharmacol Exp Ther; 1999 Apr 19; 289(1):173-80. PubMed ID: 10087001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.